Trial Profile
Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantation: A Multicenter, Open-label, Randomized, Controlled Clinical Trial in Liver Transplant Recipients With Hepatocellular Carcinoma
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Mycophenolate mofetil; Steroids; Tacrolimus
- Indications Liver transplant rejection
- Focus Therapeutic Use
- 20 Apr 2018 New trial record